Singular Health Group
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 21 July 2026
- Reported shorts
- 1.4K
- Shares on issue
- 324.273M
Singular Health Group (SHG) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $1.4Mvs $203.1K (FY25)
- Yahoo Finance, as at 14 Oct 2026
- NPAT
- −$6.3Mvs −$6.4M (FY25)
- Yahoo Finance, as at 14 Oct 2026
- EPS (diluted)
- −$0.020T (source: Derived: trailing 12 months at year end)vs −$0.027 (FY25)
- Derived: trailing 12 months at year end, as at 14 Oct 2026
- Rev YoY
- n/mFY
- EPS YoY
- n/aTTM
- Derived: trailing 12 months at year end
Summary of Appendix 4E and Annual Report to Shareholders, 31 Aug 2026
Singular Health Group reported FY26 revenue of $1.43 million, up 507% from $0.24 million, while the net loss narrowed slightly to $6.34 million from $6.38 million. No dividend was paid or declared for the period. The company did not provide forward guidance in this report.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 15 Oct 2026
- Gross margin
- 100.0%
- Operating margin
- −507.4%
- Net margin
- −443.9%
- FCF margin
- −381.3%
- ROE
- −53.7%
- ROA
- −49.8%
- FCF conversion
- n/a
- Net cash (excl. leases)
- $2.4M
- Net debt / EBITDA
- n/a
- Current ratio
- 18.2×
- Interest cover
- −732.0×
- Cash dividends paid / net profit
- n/a
- Market cap
- $51.8M
- P/E
- n/a
- P/B
- 4.9×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $1.4M | $203.1K | $90.8K | $616.1K |
| Gross profit | $1.4M | $203.1K | $90.8K | $101.6K |
| Operating income | −$7.2M | −$6.8M | −$3.9M | −$5.2M |
| EBITDA | −$6.2M | −$6.1M | −$2.9M | −$3.8M |
| EBIT | −$6.3M | −$6.3M | −$3.1M | −$4.2M |
| Interest expense | $9.9K | $10.4K | −$204.4K | $461.8K |
| Pretax income | −$6.3M | −$6.3M | −$2.9M | −$4.7M |
| Tax | $0 | $0 | $0 | $0 |
| NPAT | −$6.3M | −$6.4M | −$4.9M | −$4.7M |
| Net interest income | $434.2K | $134.0K | $216.1K | −$458.4K |
| EPS basic | −$0.020T (source: Derived: trailing 12 months at year end) | −$0.027 | −$0.031 | −$0.043 |
| EPS diluted | −$0.020T (source: Derived: trailing 12 months at year end) | −$0.027 | −$0.031 | −$0.043 |
| Shares | 323.8M | 301.7M | 195.6M | 134.0M |
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- Appendix 4E and Annual Report to ShareholdersAnnual Results31 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report28 Apr 2026via asx_announcements
- Appendix 4D Half Yearly Report and AccountsHalf Year Results24 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report27 Jan 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report20 Oct 2025via asx_announcements
- Appendix 4E and Annual Report to ShareholdersAnnual Results29 Aug 2025via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report25 Jul 2025via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report16 Apr 2025via asx_announcements
- Appendix 4D and Half Yearly Financial Report and AccountsHalf Year Results28 Feb 2025via asx_announcements
Showing 10 of 18 reports